Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/pRBK30sERxh #ClinicalTrials #HealthcareInnovation #PatientOutcomes
Jacob Malaluan’s Post
More Relevant Posts
-
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/VlIP30sEUVN #ClinicalTrials #HealthcareInnovation #PatientOutcomes
To view or add a comment, sign in
-
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/NuqA30sEAbB #ClinicalTrials #HealthcareInnovation #PatientOutcomes
To view or add a comment, sign in
-
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/39wP30sEQ1n #ClinicalTrials #HealthcareInnovation #PatientOutcomes
To view or add a comment, sign in
-
Discover how TriNetX enhances patient outcomes by designing inclusive clinical trials, assessing site feasibility, and connecting patients to suitable trials. We bring life science companies and healthcare organizations together for impactful research. Check out our Diversity solutions: https://ow.ly/Qrwv30sFjSv #ClinicalTrials #HealthcareInnovation #PatientOutcomes
To view or add a comment, sign in
-
🔍 Discover how Kitsa is revolutionizing clinical trials to unlock new patient treatment options. Our latest blog explores the impact of innovative technologies on patient care, offering insights into how these advancements are bridging the gap between research and real-world application. 💡What You’ll Learn: ⏩How Kitsa is driving innovation in clinical trials. ⏩The role of patient-centric approaches in healthcare. ⏩Success stories of accelerated treatments. 📖 Read the full blog here 🔗 https://bit.ly/3Bqn4TX #ClinicalTrials #HealthcareInnovation #PatientCare #KitsaAI
To view or add a comment, sign in
-
🙋🏻♂️ It has been an extraordinary experience attending The Synergist.org - From Testing to Targeted Treatments (FT3) meeting today, on behalf of Blueprint Medicines. Great discussion about the value of precision medicine and how partnerships and collaborations con improve the lives of patients worlwide. My key takeaways: - There is a need to continue raising awareness about precision medicine across healthcare systems - Multi-stakeholders forums are essential to ensure effective access - Collaborative approaches are the cornerstone to improve patient outcomes Congrats Helena Harnik, MBA and your team for organizing this insightful discussion. #patientadvocacy #innovation #precisionmedicine
To view or add a comment, sign in
-
At TriNetX, we are motivated by the potential for improving patients' lives. Our healthcare organizations have made huge strides in research and securing more sponsored trials, in order to achieve better patient outcomes. Learn more about what drives us: https://ow.ly/fNNr30sE69E #HealthcareInnovation #RealWorldData
To view or add a comment, sign in
-
At TriNetX, we are motivated by the potential for improving patients' lives. Our healthcare organizations have made huge strides in research and securing more sponsored trials, in order to achieve better patient outcomes. Learn more about what drives us: https://ow.ly/FmT130sCQHq #HealthcareInnovation #RealWorldData
To view or add a comment, sign in
-
Kayla Perry and Dan Knight from Merck will share insights at #ACRP2024 on how sponsors can alleviate the burden of remote monitoring on sites, In the post-pandemic era, there's a notable shift in clinical trial management, with many adopting innovative remote solutions. The session will showcase how championing site voices in technology can enhance relationships and efficiency, ultimately enabling healthcare providers to focus more on patients. Explore the full session details > https://bit.ly/3TXcQkU #GoForIt #GoForEducation #ClinicalTrials #ClinicalResearch #ClinicalResearchTechnology #FutureTrends
ACRP 2024 Speakers: Kayla Perry and Dan Knight
To view or add a comment, sign in
-
An important upcoming webinar for patient organization leaders!!! With the continued evolution of BioPharma into patient centricity, partnering with patient organizations is a critical component to understanding patient experiences and the patient journey as well as improving clinical trials (and research) for patient benefit. Patient organization impact on. BioPharma continues to evolve and expand. Join this informative webinar on collaborations, successes, areas of improvement and more… #PatientOrganizations #PatientCare #LifeSciences
📢 The 2024 Patient Organization Webinar Series will kick-off on April 25 with the webinar, Patient Organization Research Collaborations: Interactions with Life Sciences Companies. Patient organization leaders are encouraged to join Institute Executive Director Murray Aitken and Jonathan Morris of IQVIA US Healthcare Solutions for the first of this five-part series hosted throughout the year. Date: Thursday, April 25, 2024 Time: 11:00 AM Eastern Daylight Time Register here: https://lnkd.in/ehRnEdkj #PatientOrganizations #PatientCare #LifeSciences
To view or add a comment, sign in